FRANKFURT (Reuters) - Fresenius has approached potential suitors about the sale of its blood transfusion business, two people with knowledge of the matter said on Friday.
Fresenius has hired Goldman Sachs to explore the sale, the people said.
Fresenius and Goldman declined to comment.
Fresenius Chief Executive Officer Stephan Sturm said in February the company was evaluating all options for its transfusion and cell therapy unit, and that it would be a better fit for a company more focused on the business.
Earlier this month, he said Fresenius was making good progress in the process.
The Frankfurter Allgemeine Zeitung first reported Friday’s development.
Reporting by Arno Schuetze and Ludwig Burger; Writing by Tom Sims; Editing by Mark Potter